The wound care has been evolving at a rapid rate, and investors are increasingly on the lookout for companies to track. One of the companies from the sector that could be on the radars of investors this morning is SANUWAVE Health Inc. (OTCQB: SNWV), which made a major new announcement yesterday about its stock listing.
NASDAQ Listing
The leading FDA-approved wound care company announced yesterday that it had gotten the much-needed approval for the listing of its common stock on the NASDAQ Capital Market. In the news release, SANUWAVE Health announced that the trading of the common stock would begin on NASDAQ from March 7, 2025. The shares would trade under the same ticker symbol SNWV. However, at the same time, it was also revealed that the stock would continue to trade on the OTCQB up until trading commenced on the NASDAQ.
Further Information
The company went on to announce that the previous 18 months had been a time punctuated with transformation and progress. It was also noted that there was considerable excitement in the company with regards to the possibility of the uplisting of the common stock to NASDAQ.
CEO Quote
Commenting on the announcement, CEO Morgan Frank stated, “The last 18 months have been a time of transition and progress at Sanuwave, and it’s with great excitement and pride that we join the Nasdaq Global Market, one of the premier stock exchanges in the world, as the next step toward achieving our aim of transforming the wound care market and driving value for our shareholders. This is going to be fun.”
Fundamentals
| P/E Ratio | -156.11 |
| PEG Ratio | – |
| Price to Book | -1.47 |
| Price to Cash Flow | 88.5509 |
| Price to Free Cash Flow | 110.431 |
| Total Sales (TTM) | 29.30 M |
| Revenue per Share (TTM) | 9.20 |
| Shares Outstanding | 8.534 M |
| Share Float (%) | 8.21 M (96.20%) |
| % Held by Institutions | 28.29 |
